E-mail us: service@prospectnews.com Or call: 212 374 2800
Bank Loans - CLOs - Convertibles - Distressed Debt - Emerging Markets
Green Finance - High Yield - Investment Grade - Liability Management
Preferreds - Private Placements - Structured Products
 
Published on 9/4/2013 in the Prospect News Structured Products Daily.

New Issue: Morgan Stanley prices $6.59 million contingent income autocallables on Celgene

By Jennifer Chiou

New York, Sept. 4 - Morgan Stanley priced $6,594,310 of contingent income autocallable securities due Sept. 6, 2016 linked to Celgene Corp. shares, according to a 424B2 filing with the Securities and Exchange Commission.

If Celgene stock closes at or above the 80% downside threshold level on a quarterly determination date, the notes will pay a contingent payment at an annual rate of 10.05% for that quarter.

If the stock closes at or above the initial share price on any of the first 11 quarterly determination dates, the notes will be redeemed at par of $10 plus the contingent payment.

If the notes are not called, the payout at maturity will be par plus the contingent payment unless the stock finishes below the downside threshold level, in which case the payout will be a number of Celgene shares equal to $10 divided by the initial share price or, at the issuer's option, the cash equivalent.

Morgan Stanley & Co. LLC is the agent.

Issuer:Morgan Stanley
Issue:Contingent income autocallable securities
Underlying stock:Celgene Corp. (NYSE: CELG)
Amount:$6,594,310
Maturity:Sept. 6, 2016
Contingent coupon:10.05% annualized for each quarter that Celgene stock closes at or above trigger level for that quarter
Price:Par of $10
Payout at maturity:If stock finishes at or above trigger level, par plus contingent payment; otherwise, 0.07144 Celgene shares or, at issuer's option, cash equivalent
Call:At par plus contingent payment if closing share price is greater than or equal to initial share price on any of first 11 quarterly determination dates
Initial share price:$139.98
Trigger level:$104.975, 80% of initial share price
Exchange ratio:0.07144
Pricing date:Aug. 30
Settlement date:Sept. 5
Agent:Morgan Stanley & Co. LLC
Fees:2.25%
Cusip:61762P690

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.